Papers
5
Total Citations
72
H-Index
5
About
Dr. Shun-Fa Yang is a leading urologic oncologist whose research focuses on the genetic and molecular mechanisms underlying prostate cancer susceptibility, progression, and metastasis. His work has been instrumental in identifying how polymorphisms in long non-coding RNAs (lncRNAs) influence cancer risk and clinical outcomes. In a landmark 2019 study (27 citations), Dr. Yang demonstrated that a variant in the GAS5 gene significantly affects prostate cancer susceptibility and clinicopathologic features, highlighting a novel biomarker for prognosis. He further elucidated the role of MALAT1 polymorphisms in predicting lymph node metastasis (15 citations), providing critical insights for risk stratification. His investigations into carbonic anhydrase 9 expression (15 citations) and H19 polymorphisms (10 citations) have refined predictive models for patients with low PSA levels, challenging conventional risk assessments. Notably, Dr. Yang also pioneered research on the prostatic anterior fat pad as a staging tool, revealing its diagnostic value in Taiwanese populations. With a cumulative impact exceeding 70 citations across his most influential works, Dr. Yang’s contributions are advancing precision oncology, offering new avenues for early detection and personalized treatment strategies in prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5